CX3CL1 and neoplasm: In this study, using a preclinical model of melanoma that lacks CX3CL1 expression (30) and tumor-specific CD8+ T cells in which the CX3CR1 gene was replaced with a functionally unrelated gene, we have demonstrated the intratumoral generation of antigen-specific CX3CR1+ CD8+ T cells.